Literature DB >> 19584442

Lifespan profiles of Alzheimer's disease-associated genes and products in monkeys and mice.

Remi Dosunmu1, Jinfang Wu, Lina Adwan, Bryan Maloney, Md Riyaz Basha, Christopher A McPherson, G Jean Harry, Deborah C Rice, Nasser H Zawia, Debomoy K Lahiri.   

Abstract

Alzheimer's disease (AD) is characterized by plaques of amyloid-beta (Abeta) peptide, cleaved from amyloid-beta protein precursor (AbetaPP). Our hypothesis is that lifespan profiles of AD-associated mRNA and protein levels in monkeys would differ from mice and that differential lifespan expression profiles would be useful to understand human AD pathogenesis. We compared profiles of AbetaPP mRNA, AbetaPP protein, and Abeta levels in rodents and primates. We also tracked a transcriptional regulator of the AbetaPP gene, specificity protein 1 (SP1), and the beta amyloid precursor cleaving enzyme (BACE1). In mice, AbetaPP and SP1 mRNA and their protein products were elevated late in life; Abeta levels declined in old age. In monkeys, SP1, AbetaPP, and BACE1 mRNA declined in old age, while protein products and Abeta levels rose. Proteolytic processing in both species did not match production of Abeta. In primates, AbetaPP and SP1 mRNA levels coordinate, but an inverse relationship exists with corresponding protein products as well as Abeta levels. Comparison of human DNA and mRNA sequences to monkey and mouse counterparts revealed structural features that may explain differences in transcriptional and translational processing. These findings are important for selecting appropriate models for AD and other age-related diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19584442      PMCID: PMC4762220          DOI: 10.3233/JAD-2009-1138

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  79 in total

1.  Evolutionary biology. Relative differences: the myth of 1%.

Authors:  Jon Cohen
Journal:  Science       Date:  2007-06-29       Impact factor: 47.728

Review 2.  How and when environmental agents and dietary factors affect the course of Alzheimer's disease: the "LEARn" model (latent early-life associated regulation) may explain the triggering of AD.

Authors:  Debomoy K Lahiri; Bryan Maloney; Md Riyaz Basha; Yuan Wen Ge; Nasser H Zawia
Journal:  Curr Alzheimer Res       Date:  2007-04       Impact factor: 3.498

3.  Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation.

Authors:  Xian Zhang; Kun Zhou; Ruishan Wang; Jiankun Cui; Stuart A Lipton; Francesca-Fang Liao; Huaxi Xu; Yun-wu Zhang
Journal:  J Biol Chem       Date:  2007-02-15       Impact factor: 5.157

Review 4.  Knockout of REST/NRSF shows that the protein is a potent repressor of neuronally expressed genes in non-neural tissues.

Authors:  F S Jones; R Meech
Journal:  Bioessays       Date:  1999-05       Impact factor: 4.345

5.  THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies.

Authors:  Myriam Roussigne; Corinne Cayrol; Thomas Clouaire; François Amalric; Jean-Philippe Girard
Journal:  Oncogene       Date:  2003-04-24       Impact factor: 9.867

6.  Lead (Pb) exposure and its effect on APP proteolysis and Abeta aggregation.

Authors:  Md Riyaz Basha; Manjari Murali; Hasan K Siddiqi; Koyel Ghosal; Omar K Siddiqi; Hilal A Lashuel; Yuan-Wen Ge; Debomoy K Lahiri; N H Zawia
Journal:  FASEB J       Date:  2005-10-17       Impact factor: 5.191

7.  A critical function for beta-amyloid precursor protein in neuronal migration revealed by in utero RNA interference.

Authors:  Tracy L Young-Pearse; Jilin Bai; Rui Chang; Jessica B Zheng; Joseph J LoTurco; Dennis J Selkoe
Journal:  J Neurosci       Date:  2007-12-26       Impact factor: 6.167

8.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein.

Authors:  D Games; D Adams; R Alessandrini; R Barbour; P Berthelette; C Blackwell; T Carr; J Clemens; T Donaldson; F Gillespie
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

9.  The promoter of Alzheimer's disease amyloid A4 precursor gene.

Authors:  J M Salbaum; A Weidemann; H G Lemaire; C L Masters; K Beyreuther
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

Review 10.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

View more
  14 in total

Review 1.  Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications.

Authors:  Debomoy K Lahiri; Bryan Maloney
Journal:  Exp Neurol       Date:  2010-05-05       Impact factor: 5.330

2.  BACE2 expression increases in human neurodegenerative disease.

Authors:  Christopher J Holler; Robin L Webb; Ashley L Laux; Tina L Beckett; Dana M Niedowicz; Rachel R Ahmed; Yinxing Liu; Christopher R Simmons; Amy L S Dowling; Angela Spinelli; Moshe Khurgel; Steven Estus; Elizabeth Head; Louis B Hersh; M Paul Murphy
Journal:  Am J Pathol       Date:  2011-11-07       Impact factor: 4.307

3.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

4.  Genome-wide expression and methylation profiling in the aged rodent brain due to early-life Pb exposure and its relevance to aging.

Authors:  Remi Dosunmu; Hany Alashwal; Nasser H Zawia
Journal:  Mech Ageing Dev       Date:  2012-05-18       Impact factor: 5.432

5.  Functional activity of the novel Alzheimer's amyloid β-peptide interacting domain (AβID) in the APP and BACE1 promoter sequences and implications in activating apoptotic genes and in amyloidogenesis.

Authors:  Jason A Bailey; Bryan Maloney; Yuan-Wen Ge; Debomoy K Lahiri
Journal:  Gene       Date:  2011-06-25       Impact factor: 3.688

6.  Histone acetylation maps in aged mice developmentally exposed to lead: epigenetic drift and Alzheimer-related genes.

Authors:  Aseel Eid; Syed Waseem Bihaqi; Christopher Hemme; John M Gaspar; Ronald P Hart; Nasser H Zawia
Journal:  Epigenomics       Date:  2018-05-03       Impact factor: 4.778

7.  Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Gehad M Subaiea; Nasser H Zawia
Journal:  Alzheimers Dement       Date:  2013-07-15       Impact factor: 21.566

8.  Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.

Authors:  Bryan Maloney; Yuan-Wen Ge; Ronald C Petersen; John Hardy; Jack T Rogers; Jordi Pérez-Tur; Debomoy K Lahiri
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-01-05       Impact factor: 3.568

9.  Evaluation of Amyloid Protective Factors and Alzheimer Disease Neurodegeneration Protective Factors in Elderly Individuals.

Authors:  Prashanthi Vemuri; David S Knopman; Timothy G Lesnick; Scott A Przybelski; Michelle M Mielke; Jonathan Graff-Radford; Melissa E Murray; Rosebud O Roberts; Maria Vassilaki; Val J Lowe; Mary M Machulda; David T Jones; Ronald C Petersen; Clifford R Jack
Journal:  JAMA Neurol       Date:  2017-06-01       Impact factor: 18.302

10.  PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE).

Authors:  Debomoy K Lahiri; Bryan Maloney; Jack T Rogers; Yuan-Wen Ge
Journal:  BMC Genomics       Date:  2013-01-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.